hydroxyurea has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Lu, Q | 1 |
| Valdivielso, JM | 1 |
| Montero, A | 1 |
| Munger, KA | 1 |
| Badr, KF | 1 |
2 other studies available for hydroxyurea and Alloxan Diabetes
| Article | Year |
|---|---|
Hydroxyurea protects against diabetic cardiomyopathy by inhibiting inflammation and apoptosis.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Diabetes Mellitus, Experimental; Diabetic Cardiom | 2022 |
Inhibition of 5-LO activating protein (FLAP) activity decreases proteinuria in streptozotocin (STZ)-induced diabetic rats.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Blood Glucose; Blood Urea Nitrogen; Carrier Proteins; D | 2002 |